RadarScope: NVO — Analiza Fundamentala

Market Cap

$208.6B

P/E Ratio

11.5

Profit Margin

35.3%

ROE

59.1%

📈 Earnings Report — 2026-08

Ultimul trimestru raportat

EPS Actual

$0.96

▼ 7.7% QoQ▼ 1.0% YoY

EPS Estimat

$0.77

Beat by 24.7%

Revenue Actual

$12.13B

▲ 10.0% QoQ▲ 1.3% YoY

Revenue Estimat

$10.89B

Beat by 11.3%

Istoric Ultimele 4 Trimestre

2026-08

EPS Actual

$0.96

EPS Est.

$0.77

Revenue

$12.13B

Beat/Miss

Beat by 24.7%

2026-05

EPS Actual

$1.04

EPS Est.

$0.87

Revenue

$11.02B

Beat/Miss

Beat by 19.5%

2026-02

EPS Actual

EPS Est.

$0.9

Revenue

$12.50B

Beat/Miss

Beat by 11.1%

2025-11

EPS Actual

$1.02

EPS Est.

$0.77

Revenue

$11.53B

Beat/Miss

Beat by 32.5%

Urmatorul Raport

Data

2026-11-04

EPS Estimat

$0.8

Revenue Estimat

$11.22B

💰 Dividende Recente

2026-08

$0.579

Yield: 2.59%

Plata: 2026-08

2025-08

$0.584

Yield: 3.21%

Plata: 2025-08

2025-03

$1.143

Yield: 2.39%

Plata: 2025-04

2024-08

$0.517

Yield: 1.07%

Plata: 2024-08

📊 Scoruri Companie

Crestere 9/10

Revenue & Profit Growth

Evaluare 7/10

P/E · P/B · P/S

Calitate 10/10

Marje · ROE · Datorii

Risc 3/10

Beta · Market Cap

📈 Date Financiare Istorice in miliarde USD

💰 Revenue

📊 Net Profit

💵 Cash Flow

Operating (albastru) · Free (violet)

🏦 Cash & Datorii

Cash (verde) · Long-term Debt (rosu)

💸 Operating Expenses

🤖 Analiza RadarScope AI

Analiza AI (verdict, bull case, bear case) este disponibila pe planurile Trader si Elite.

💡 Disponibil pe Trader / Elite

🐂 BULL CASE

Disponibil pe Trader / Elite

🐻 BEAR CASE

Disponibil pe Trader / Elite

TINE Upgrade la Trader sau Elite pentru verdictul AI.

📖 Indicatorii lui Lynch — concluzii rapide dupa Peter Lynch

PEG — P/E in contextul cresterii

ATRACTIV

PEG 0.56 · cu dividend 0.5 · crestere EPS ~20.6%/an. Regula Lynch: ~1 corect, sub 0.5 foarte atractiv, peste 2 scump.

P/E vs istoria proprie si sectorul

P/E acum 11.5.
vs media proprie 5 ani (30.4): SUB media sa
vs sector Healthcare (22.7): SUB sector
Lynch: compara P/E cu propria istorie si media industriei, nu in absolut.

Procentul din vanzari

VERIFICA MANUAL

Segmentare pe produse indisponibila la aceasta firma. Verifica in raport cat reprezinta produsul care te intereseaza din venituri — sub ~10% nu misca actiunea.

Cash si datorie

DATORIE NETA

Datorie neta pe actiune $21.49 (mai multa datorie decat cash).
Datorie/Capital 0.63 DATORIE MODERATA — decide supravietuirea in vremuri grele (esential la ciclice si turnarounds).
Tip datorie: OK — TERMEN LUNG — majoritar pe termen lung (obligatiuni = timp de manevra). Scurt $12.0B / Lung $110.4B.

Marje de profit

MARJE SOLIDE

Bruta 80.6% · Operationala 43.1% · Neta 35.3%. Marje mari — de regula castigatorul pe termen lung din industrie.

Inventare vs vanzari

ATENTIE

Stocurile cresc mai repede ca vanzarile (inventar +21% vs vanzari +6%) — semnal de alarma clasic.

Povestea in 2 minute

De ce o detii: Analiza AI (verdict, bull case, bear case) este disponibila pe planurile Trader si Elite.
Ce trebuie sa mearga bine: Disponibil pe Trader / Elite
Obstacole: Disponibil pe Trader / Elite
Lynch: daca nu poti explica coerent in 2 minute de ce o detii, nu o intelegi.

🔬 Analiza Fundamentala Avansata · an fiscal 2025-12-31

🏦 Altman Z-Score

2.15 ZONA GRI

X1 Capital de lucru / Active	-0.08	x1.2
X2 Profit reportat / Active	0.36	x1.4
X3 EBIT / Active	0.248	x3.3
X4 Capitalizare / Datorii	0.596	x0.6
X5 Vanzari / Active	0.569	x1.0

Praguri Altman (1968): >2,99 sigur · 1,81–2,99 gri · <1,81 pericol de faliment

💪 Piotroski F-Score

5/9 ACCEPTABIL

✓ROA pozitiv18.87%

✓Cash flow operational pozitiv119.10B

✗ROA in crestere18.87% vs 21.69%

✓Cash flow > Profit net (calitate)119.10B vs 102.43B

✗Datorie pe termen lung in scadere20.6% vs 18.1% din active

✓Lichiditate curenta in crestere0.80 vs 0.74

✓Fara emisiune de actiuni noi4443.5M vs 4441.3M

✗Marja bruta in crestere81.0% vs 84.7%

✗Rotatia activelor in crestere0.57 vs 0.62

9 teste binare (Piotroski, 2000). 8–9 = putere financiara · 0–2 = slabiciune

⚖️ ROIC vs WACC

+30.69pp CREEAZA VALOARE

ROIC (randamentul capitalului)	35.42%
WACC (costul capitalului)	4.73%

Ipoteze (la vedere):
Rata fara risc 4.2% (USD) · Beta 0.35 · Prima de risc 5.5%
Cost capitaluri proprii 6.12% · Cost datorie 3.21% · Impozit efectiv 21.5%

Metode publice: Altman, E. (1968), Journal of Finance · Piotroski, J. (2000), Journal of Accounting Research · ROIC/WACC prin CAPM. Fiecare cifra isi arata componentele si pragurile — poti reface calculul manual.

📊 Metrici Fundamentale

P/E TTM11.5

P/B TTM6.02

P/S TTM4.06

EV/EBITDA8.3

Gross Margin80.6%

Operating Margin43.1%

Net Margin35.3%

ROE59.1%

ROA19.6%

Debt/Equity0.63

Current Ratio0.87

FCF Yield3.7%

Dividend Yield2.49%

Beta0.35

💰 Venituri & Profit (ultimele trimestre)

Trimestru	Revenue	Gross Profit	Net Income	EPS
2026-06	$78.5B	$61.4B	$21.0B	$4.74
2026-03	$96.8B	$83.2B	$48.6B	$10.93
2025-12	$79.1B	$64.0B	$26.9B	$6.06
2025-09	$75.0B	$57.1B	$20.0B	$4.50

🏢 Profil Companie

CEOMaziar Mike Doustdar

Angajati68794

IPO1981-04-30

Websitehttps://www.novonordisk.com...

52W High$64.16

52W Low$35.12

Novo Nordisk A/S is a global pharmaceutical firm dedicated to the investigation, creation, manufacturing, and distribution of medicinal products across a vast international footprint. Its market presence extends throughout Europe, the Middle East, Africa, various parts of Asia (including Mainland China, Hong Kong, and Taiwan), and North America. The company's operations are structured into two principal business units: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care di...

🎯 Score Breakdown

Calitate Companie (Q) 10/10

Risc Speculativ (R) 3/10

Scor AI RadarScope 0/100

VERDICT FINAL

TINE

Upgrade la Trader sau Elite pentru verdictul AI.

🔒 Analiza completa disponibila cu cont SignalRadar